companiesCompany
Pierre Fabre
Pierre Fabre is a French pharmaceutical and dermo-cosmetics group whose oncology franchise includes vinorelbine (Navelbine), vinflunine (Javlor) and the BRAF/MEK pair encorafenib and binimetinib in Europe.
Overview
Pierre Fabre originated the vinca alkaloids vinorelbine and vinflunine, markets Braftovi (encorafenib) and Mektovi (binimetinib) in Europe under licence from Array/Pfizer, and sells busulfan (Busilvex) and other haematology products.
Headquarters
Castres, FR
Scorecard
All companies#122of 680 companies, score 20
- approved products +6
- modalities +2
- regions +1
- registry trials +11
1 approved, 0 in phase 3, 0 earlier, 0 targets, 29 registry studies. Formula on the scorecards page.
Type
pharma
Website